Metropolitan Life Insurance Company (MetLife)’s Halozyme HALO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,821	Closed	-$277K	–	910
2024 Q1	$277K	Sell	6,821 -556	-8%	-$20.8K	0.01%	605
2023 Q4	$273K	Sell	7,377 -309	-4%	-$11.6K	0.01%	604
2023 Q3	$294K	Buy	7,686 +385	+5%	+$15.8K	0.02%	555
2023 Q2	$263K	Buy	7,301 +106	+1%	+$3.62K	0.01%	578
2023 Q1	$275K	Sell	7,195 -1,013	-12%	-$47.5K	0.01%	570
2022 Q4	$467K	Buy	8,208 +30	+0.4%	+$1.54K	0.02%	501
2022 Q3	$323K	Hold	8,178	–	–	0.02%	547
2022 Q2	$360K	Sell	8,178 -517	-6%	-$22.4K	0.02%	542
2022 Q1	$347K	Sell	8,695 -49,044	-85%	-$1.75M	0.01%	606
2021 Q4	$2.32M	Sell	57,739 -2,679	-4%	-$100K	0.03%	452
2021 Q3	$2.46M	Sell	60,418 -390	-0.6%	-$16.3K	0.04%	412
2021 Q2	$2.76M	Buy	60,808 +4,367	+8%	+$193K	0.04%	383
2021 Q1	$2.35M	Sell	56,441 -1,808	-3%	-$82.5K	0.04%	450
2020 Q4	$2.49M	Buy	58,249 +18,298	+46%	+$658K	0.04%	392
2020 Q3	$1.05M	Sell	39,951 -2,343	-6%	-$65.2K	0.02%	717
2020 Q2	$1.13M	Buy	42,294 +1,779	+4%	+$40.1K	0.02%	666
2020 Q1	$729K	Sell	40,515 -5,021	-11%	-$95.3K	0.02%	836
2019 Q4	$807K	Sell	45,536 -1,130	-2%	-$19.6K	0.01%	1025
2019 Q3	$724K	Buy	46,666 +4,755	+11%	+$78.3K	0.01%	1056
2019 Q2	$720K	Buy	41,911 +1,279	+3%	+$20.6K	0.01%	1082
2019 Q1	$654K	Hold	40,632	–	–	0.01%	1128
2018 Q4	$594K	Hold	40,632	–	–	0.01%	1089
2018 Q3	$738K	Hold	40,632	–	–	0.01%	1096
2018 Q2	$685K	Buy	40,632 +2,288	+6%	+$43.3K	0.01%	1113
2018 Q1	$751K	Buy	38,344 +748	+2%	+$14.5K	0.01%	1037
2017 Q4	$762K	Sell	37,596 -42,008	-53%	-$772K	0.01%	1029
2017 Q3	$1.38M	Buy	79,604 +5,127	+7%	+$69.4K	0.01%	1087
2017 Q2	$955K	Hold	74,477	–	–	0.01%	1266
2017 Q1	$965K	Sell	74,477 -1,162	-2%	-$14.7K	0.01%	1250
2016 Q4	$747K	Sell	75,639 -1,173	-2%	-$12.8K	0.01%	1472
2016 Q3	$928K	Buy	76,812 +223	+0.3%	+$2.28K	0.01%	1323
2016 Q2	$661K	Sell	76,589 -2,225	-3%	-$22K	﹤0.01%	1519
2016 Q1	$746K	Buy	78,814 +4,309	+6%	+$40.5K	0.01%	1329
2015 Q4	$1.29M	Sell	74,505 -1,758	-2%	-$28K	0.01%	1054
2015 Q3	$1.02M	Hold	76,263	–	–	0.01%	1180
2015 Q2	$1.72M	Sell	76,263 -4,199	-5%	-$73.8K	0.01%	1020
2015 Q1	$1.15M	Buy	80,462 +3,609	+5%	+$52K	0.01%	1135
2014 Q4	$742K	Buy	76,853 +2,195	+3%	+$19.5K	0.01%	1516
2014 Q3	$679K	Hold	74,658	–	–	﹤0.01%	1518
2014 Q2	$738K	Hold	74,658	–	–	0.01%	1552
2014 Q1	$948K	Buy	74,658 +365	+0.5%	+$5.42K	0.01%	1384
2013 Q4	$1.11M	Hold	74,293	–	–	0.01%	1259
2013 Q3	$820K	Buy	74,293 +996	+1%	+$8.3K	0.01%	1412
2013 Q2	$582K	Buy	+73,297	New	+$467K	﹤0.01%	1599

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s HALO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Halozyme (HALO) in Q2 2024, closing a stake of 6,821 shares — an estimated $277K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HALO in Q2 2013 and held it in 44 quarters. The position peaked at $2.76M in Q2 2021. 460 funds tracked by Wall St. Rank hold HALO as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Halozyme position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 6,821 Halozyme shares in Q2 2024, an estimated $277K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Halozyme in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Halozyme position peaked at $2.76M in Q2 2021.
460 funds tracked by Wall St. Rank held Halozyme as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.